| scholarly article | Q13442814 |
| P50 | author | Makoto Otsu | Q42795809 |
| Nao Suzuki | Q82599260 | ||
| Hiromitsu Nakauchi | Q106558120 | ||
| P2093 | author name string | Satoshi Yamazaki | |
| Satoshi Takaki | |||
| Tomoyuki Yamaguchi | |||
| Hideki Masaki | |||
| Motohito Okabe | |||
| P2860 | cites work | Enhanced hematopoiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk | Q24675202 |
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Generation of germline-competent induced pluripotent stem cells | Q28131699 | ||
| Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction | Q28287126 | ||
| Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1 | Q28290118 | ||
| The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells | Q28593119 | ||
| SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells | Q29615006 | ||
| Osteoblastic cells regulate the haematopoietic stem cell niche | Q29615007 | ||
| Identification of the haematopoietic stem cell niche and control of the niche size | Q29615008 | ||
| Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin | Q29619238 | ||
| Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis | Q33358404 | ||
| Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells | Q33392928 | ||
| Niche recycling through division-independent egress of hematopoietic stem cells | Q33591065 | ||
| HOXB4 enforces equivalent fates of ES-cell-derived and adult hematopoietic cells. | Q33922993 | ||
| In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. | Q34034653 | ||
| Hematopoietic and endothelial differentiation of human induced pluripotent stem cells | Q34099344 | ||
| Definitive-like erythroid cells derived from human embryonic stem cells coexpress high levels of embryonic and fetal globins with little or no adult globin | Q35848983 | ||
| Embryonic stem cells as an alternate marrow donor source: engraftment without graft-versus-host disease | Q36399399 | ||
| Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients | Q36812729 | ||
| Embryonic stem cell tumor model reveals role of vascular endothelial receptor tyrosine phosphatase in regulating Tie2 pathway in tumor angiogenesis | Q37477150 | ||
| Blood formation in a clonal cell line of mouse teratocarcinoma | Q42802933 | ||
| Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression | Q42972247 | ||
| Little evidence for developmental plasticity of adult hematopoietic stem cells | Q48491467 | ||
| Hematopoietic stem cell repopulating ability can be maintained in vitro by some primary endothelial cells. | Q50784146 | ||
| HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. | Q52121270 | ||
| Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. | Q54526374 | ||
| Inability of human induced pluripotent stem cell-hematopoietic derivatives to downregulate microRNAs in vivo reveals a block in xenograft hematopoietic regeneration | Q62001614 | ||
| Inability of Human Induced Pluripotent Stem Cell-Hematopoietic Derivatives to Downregulate MicroRNAs In Vivo Reveals a Block in Xenograft Hematopoietic Regeneration | Q62001619 | ||
| Hematopoietic Engraftment of Human Embryonic Stem Cell-Derived Cells Is Regulated by Recipient Innate Immunity | Q64008483 | ||
| Definitive red blood cell differentiation in a clonal line of mouse teratocarcinoma cultured in vivo in the chick embryo | Q67018868 | ||
| Presence of multipotential hemopoietic cells in teratocarcinoma cultures | Q70877962 | ||
| Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants | Q73138491 | ||
| Hematopoietic microchimerism in sheep after in utero transplantation of cultured cynomolgus embryonic stem cells | Q81407025 | ||
| Quantification of self-renewal capacity in single hematopoietic stem cells from normal and Lnk-deficient mice | Q81813892 | ||
| Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche | Q82685074 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1424-1431 | |
| P577 | publication date | 2013-05-14 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation | |
| P478 | volume | 21 |
| Q37299126 | A synthetic three-dimensional niche system facilitates generation of functional hematopoietic cells from human-induced pluripotent stem cells. |
| Q39017189 | A view of human haematopoietic development from the Petri dish |
| Q60952855 | Biobanking Organoids or Ground-State Stem Cells? |
| Q42712866 | Bottlenecks in deriving definitive hematopoietic stem cells from human pluripotent stem cells: a CIRM mini-symposium and workshop report |
| Q55103663 | CXCL12/CXCR4 Signaling Enhances Human PSC-Derived Hematopoietic Progenitor Function and Overcomes Early In Vivo Transplantation Failure. |
| Q64274728 | Cancer Immunotherapies and Humanized Mouse Drug Testing Platforms |
| Q36934797 | Cell Therapy Strategies to Combat Immunosenescence |
| Q34267315 | Cell replacement therapies: is it time to reprogram? |
| Q38366376 | Cell therapies for treatment of human immunodeficiency virus infection |
| Q42060470 | Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations |
| Q36860891 | Cloning and variation of ground state intestinal stem cells |
| Q90836371 | Cloning of ground-state intestinal stem cells from endoscopic biopsy samples |
| Q37712423 | Cocktail of chemical compounds robustly promoting cell reprogramming protects liver against acute injury |
| Q37633372 | Concise Review: Getting to the Core of Inherited Bone Marrow Failures. |
| Q38889169 | Concise Review: Recent Advances in the In Vitro Derivation of Blood Cell Populations |
| Q90752195 | Concise Review: Towards the Clinical Translation of Induced Pluripotent Stem Cell-Derived Blood Cells-Ready for Take-Off |
| Q33409483 | Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling |
| Q35889520 | Converting cell fates: generating hematopoietic stem cells de novo via transcription factor reprogramming |
| Q92996966 | Current Advances in Red Blood Cell Generation Using Stem Cells from Diverse Sources |
| Q35533599 | De novo generation of HSCs from somatic and pluripotent stem cell sources |
| Q38877308 | Development of autologous blood cell therapies |
| Q35676075 | Development of hematopoietic stem and progenitor cells from human pluripotent stem cells |
| Q35944308 | Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines |
| Q41813455 | Emergence of CD43-Expressing Hematopoietic Progenitors from Human Induced Pluripotent Stem Cells |
| Q38993825 | Emerging cellular and gene therapies for congenital anemias. |
| Q38893818 | Emerging concepts for the in vitro derivation of murine haematopoietic stem and progenitor cells |
| Q33815740 | Engineering the haemogenic niche mitigates endogenous inhibitory signals and controls pluripotent stem cell-derived blood emergence |
| Q38187494 | Ex vivo production of platelets from stem cells |
| Q36756725 | From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa |
| Q45874318 | Gene and Cell Therapy for β-Thalassemia and Sickle Cell Disease with Induced Pluripotent Stem Cells (iPSCs): The Next Frontier |
| Q38846192 | Gene editing and its application for hematological diseases |
| Q90744990 | Gene editing of PKLR gene in human hematopoietic progenitors through 5' and 3' UTR modified TALEN mRNA |
| Q91841922 | Gene therapy of hematological disorders: current challenges |
| Q27007012 | Gene therapy on the move |
| Q38890095 | Generating human hematopoietic stem cells in vitro -exploring endothelial to hematopoietic transition as a portal for stemness acquisition |
| Q34354372 | Generation and homing of iPSC-derived hematopoietic cells in vivo |
| Q35184193 | Generation of X-CGD cells for vector evaluation from healthy donor CD34(+) HSCs by shRNA-mediated knock down of gp91(phox). |
| Q37740413 | Generation of hematopoietic stem cells from human embryonic stem cells using a defined, stepwise, serum-free, and serum replacement-free monolayer culture method |
| Q37725454 | Generation of in vivo neural stem cells using partially reprogrammed cells defective in in vitro differentiation potential |
| Q26851475 | Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells |
| Q26771763 | Hematopoietic stem cell expansion and generation: the ways to make a breakthrough |
| Q57817724 | Human Teratoma-Derived Hematopoiesis Is a Highly Polyclonal Process Supported by Human Umbilical Vein Endothelial Cells |
| Q38662832 | Human haematopoietic stem cell development: from the embryo to the dish |
| Q92087312 | Human-induced pluripotent stem cells derived hematopoietic progenitor cells for treatment of hematopoietic failure among trauma hemorrhagic shock patients |
| Q38196608 | Humanized mouse models in transplantation research |
| Q50237862 | In vitro generation of blood red cells from stem cells: a sketch of the future |
| Q36264901 | In vivo differentiation of induced pluripotent stem cells into neural stem cells by chimera formation. |
| Q91807457 | In vivo generated hematopoietic stem cells from genome edited induced pluripotent stem cells are functional in platelet-targeted gene therapy of murine hemophilia A |
| Q27016090 | Induced pluripotent stem cells in hematology: current and future applications |
| Q35037783 | Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery |
| Q90307109 | Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic coculture |
| Q46063788 | Inferring Cell-State Transition Dynamics from Lineage Trees and Endpoint Single-Cell Measurements |
| Q52723487 | Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa. |
| Q46334215 | Interspecies chimeras for human stem cell research. |
| Q42376275 | In Vivo Generation of Engraftable Murine Hematopoietic Stem Cells by Gfi1b, c-Fos, and Gata2 Overexpression within Teratoma |
| Q64249239 | Long-Term Engraftment of ESC-Derived B-1 Progenitor Cells Supports HSC-Independent Lymphopoiesis |
| Q52874167 | Long-term skin regeneration in xenografts from iPSC teratoma-derived human keratinocytes. |
| Q26801840 | Lost in translation: pluripotent stem cell-derived hematopoiesis |
| Q49846320 | Maintenance of hematopoietic stem and progenitor cells in fetal intra-aortic hematopoietic clusters by the Sox17-Notch1-Hes1 axis |
| Q35829658 | Making a Hematopoietic Stem Cell |
| Q28083303 | Modeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome Engineering |
| Q39456721 | Modeling Normal and Disordered Human Hematopoiesis |
| Q92570903 | Modeling blood diseases with human induced pluripotent stem cells |
| Q52358133 | Modeling cancer using patient-derived induced pluripotent stem cells to understand development of childhood malignancies. |
| Q33587018 | Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells |
| Q42175634 | Mouse embryonic dorsal root ganglia contain pluripotent stem cells that show features similar to embryonic stem cells and induced pluripotent stem cells |
| Q36293848 | Multiple sclerosis: getting personal with induced pluripotent stem cells |
| Q47220242 | Murine pluripotent stem cells that escape differentiation inside teratomas maintain pluripotency |
| Q57624392 | Notch and Aryl Hydrocarbon Receptor Signaling Impact Definitive Hematopoiesis from Human Pluripotent Stem Cells |
| Q35582332 | Placenta-based therapies for the treatment of epidermolysis bullosa |
| Q48163717 | Pluripotent Stem Cell-Derived Hematopoietic Progenitors Are Unable to Downregulate Key Epithelial-Mesenchymal Transition-Associated miRNAs. |
| Q26824479 | Progress and obstacles towards generating hematopoietic stem cells from pluripotent stem cells |
| Q38977109 | Progress towards generation of human haematopoietic stem cells |
| Q45858391 | Reactive Oxygen Species Impair the Function of CD90+ Hematopoietic Progenitors Generated from Human Pluripotent Stem Cells |
| Q65002709 | Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders. |
| Q35637089 | Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model. |
| Q37589437 | Role of mesenchymal stem cells in cell life and their signaling |
| Q91792443 | Seeking the "mother of blood" from human pluripotent stem cells: Are we there yet? |
| Q89446460 | Skeletal Muscle Stem Cells from PSC-Derived Teratomas Have Functional Regenerative Capacity |
| Q38258077 | Skeletal muscle tissue engineering: strategies for volumetric constructs |
| Q28271278 | Survival regulation of leukemia stem cells |
| Q39063423 | Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation |
| Q38677423 | Teratoma: from spontaneous tumors to the pluripotency/malignancy assay |
| Q27329605 | The RUNX1 +24 enhancer and P1 promoter identify a unique subpopulation of hematopoietic progenitor cells derived from human pluripotent stem cells |
| Q36627127 | The hematopoietic system in the context of regenerative medicine |
| Q28076397 | Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine |
| Q88240704 | Transplantation of human-induced pluripotent stem cells carried by self-assembling peptide nanofiber hydrogel improves bone regeneration in rat calvarial bone defects |
| Q92741058 | Understanding the Journey of Human Hematopoietic Stem Cell Development |
| Q58116145 | Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate |
| Q87798225 | [Generation of engraftable hematopoietic stem cells from human pluripotent stem cells] |
| Q26751506 | hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine |
| Q55398510 | iPS Cells-The Triumphs and Tribulations. |
| Q58792171 | iPSC-Derived Macrophages Effectively Treat Pulmonary Alveolar Proteinosis in Csf2rb-Deficient Mice |
Search more.